Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study
Ke Su,Yanlin Liu,Pan Wang,Kun He,Fei Wang,Hao Chi,Mingyue Rao,Xueting Li,Lianbin Wen,Yanqiong Song,Jianwen Zhang,Tao Gu,Ke Xu,Qi Li,Jiali Chen,Zhenying Wu,Han Li,Weihong Huang,Lan Chen,Jian Tong,Hongyan Li,Xunjie Feng,Siyu Chen,Binbin Yang,Hongping Jin,Yue Yang,Hanlin Liu,Chao Yang,Ming Wu,Fangyu Xiong,Keyi Peng,Lechuan Zhu,Yaoyang Xu,Xue Tang,Zunyuan Tan,Xiaotong Luo,Hanyue Zheng,Yuxin Zhang,Lu Guo,Yunwei Han
DOI: https://doi.org/10.1007/s12072-022-10391-y
IF: 9.029
2022-08-17
Hepatology International
Abstract:Although the diagnostic value of plasma heat-shock protein 90α (HSP90α) in hepatocellular carcinoma (HCC) has been previously reported, the causal effect of the plasma HSP90α levels on HCC prognosis remains largely unclear. To this extent, we sought to assess whether the plasma HSP90α acts as a prognostic factor for HCC patients.
gastroenterology & hepatology